Skip to main content

Use of Imaging Studies for Low Back Pain

CBE ID
0052
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of diagnosis.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.20 Types of Data Sources
      1.14 Numerator

      Patients who received an imaging study (x-ray, CT, MRI) within the 28 days following a diagnosis of low back pain.

      1.15 Denominator

      All patients 18 years as of January 1 of the measurement year to 50 years as of December 31 of the measurement year with a claim/encounter for an outpatient, observation, emergency department, physical therapy, or telehealth visit, or osteopathic or chiropractic manipulative treatment, with a principal diagnosis of low back pain during the Intake Period (January 1 – December 3 of the measurement year).

      Exclusions

      Because the intent of the measure is to assess imaging for patients with a new episode of low back pain, exclude patients with a recent diagnosis of low back pain.

      Also, exclude any patient who had a diagnosis for which imaging is clinically appropriate. Any of the following meet criteria:

      (1) Cancer
      (2) Trauma
      (3) Recent IV drug abuse
      (4) Neurologic impairment
      (5) HIV
      (6) Spinal infection
      (7) Major organ transplant
      (8) Prolonged use of corticosteroids

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed 2016-2017 Off-Cycle Activities: Measure Review
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      National Committee for Quality Assurance
      Steward POC email
      measureendorsement@ncqa.org
      Steward Organization Copyright

      © [2005] by the National Committee for Quality Assurance
      1100 13th Street, NW, Suite 1000
      Washington, DC 20005

                Public Comments